Literature DB >> 26001067

Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives.

Rajabrata Bhuyan1, Alpana Seal2.   

Abstract

Kv1.3 is one of the widely distributed Shaker type voltage gated potassium channel which performs the outward flow of K(+) ions in excitable cells. In immunological synapse, Kv1.3 plays a pivotal role in antigen dependent activation and proliferation of lymphocytes along with the KCa3.1. The up-regulation of Kv1.3 leads to several T-cell-mediated autoimmune diseases, hence considered as an attractive pharmacological drug target. Here, we have employed molecular modeling, docking and simulation techniques to examine the dynamical properties of Kv1.3 in both open and closed state conformation embedded in DPPC membrane as well as its modes of inhibition against the popularly known scorpion venom OSK1 and its three mutant analogues. The Kv1.3 in open conformation took comparatively more time to get stabilized than the closed state. Both conformations ascertain their stability and the transition between closed to active states is more consistent with the paddle model of channel gating. The binding modes of channel-toxin complexes are well established by identifying strongly interacting amino acids lining at their polar surfaces. Our findings suggest that, two mutant derivatives OSK1-K16,D20 & OSK1-P12,K16,D20 have increased inhibitory potency against Kv1.3. We also pointed out some particular residues responsible for binding of OSK1 with Kv1.3 over other Shaker-type ion channels. We believe that the insights came from Kv1.3-OSK1 interaction will be valuable in pharmacological studies for strategic development of both potent and selective therapeutic drugs against T-cell-mediated autoimmune diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Inhibition; K(+) channel; MD simulation; OSK1; Shaker-type; Voltage-gated

Mesh:

Substances:

Year:  2015        PMID: 26001067     DOI: 10.1016/j.bpc.2015.04.004

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  4 in total

Review 1.  Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.

Authors:  Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič
Journal:  Med Res Rev       Date:  2021-05-01       Impact factor: 12.944

2.  Eplerenone Reverses Cardiac Fibrosis via the Suppression of Tregs by Inhibition of Kv1.3 Channel.

Authors:  Pei-Pei Shao; Chang-Jiang Liu; Qi Xu; Bo Zhang; Shao-Hua Li; Yang Wu; Zhan Sun; Lu-Feng Cheng
Journal:  Front Physiol       Date:  2018-07-13       Impact factor: 4.566

Review 3.  Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.

Authors:  Xiaoli Wang; Guoyi Li; Jingkang Guo; Zhiping Zhang; Shuzhang Zhang; Yudan Zhu; Jiwei Cheng; Lu Yu; Yonghua Ji; Jie Tao
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

Review 4.  Review on Biological Characteristics of Kv1.3 and Its Role in Liver Diseases.

Authors:  Junda Liu; Xiong-Wen Lv; Lei Zhang; Hua Wang; Jun Li; Baoming Wu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.